(a) Ankylosing spondylitis and psoriasis: main target areas on vertebral column and girdle joints (b) Crohn disease and ulcerative colitis: main target.
Source: Low back pain, Murtagh s General Practice, 6e. Citation: Murtagh J. Murtagh s General Practice, 6e; 2015 Available at: image=/data/books/1522/murtagh6e_ch38_010.png&sec= &BookID=1522&ChapterSecID= &imagename= Accessed: November 05, Copyright © 2017 McGraw-Hill Education. All rights reserved.
17 Effects of Ankylosing Spondylitis on the Body
PDF] Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis - ScienceDirect
Frontiers Managing Psoriatic Arthritis With Inflammatory Bowel Disease and/or Uveitis
Psoriatic Arthritis: Symptoms, Causes, and Treatment
IL-17A Inhibition: A Treatment Option for Psoriatic Arthritis With Axial Involvement - Rheumatology Advisor
Psoriatic Arthritis - Symptoms, Causes and Treatment Options
Advances in the management of psoriatic arthritis
Murtagh's general practice [8 ed.]
Psoriatic Arthritis vs. Lupus: Signs, Causes, Treatment
Biologics for Psoriatic Arthritis: Getting Started and What To Know
PDF) Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs
Frontiers Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
Psoriatic arthritis can potentially lead to permanent deformity and disability.